| Dr Michael R Caudle, MD | |
|
2018 Western Ave, Knoxville, TN 37921-5718 | |
| (865) 544-0406 | |
| (865) 544-0480 |
| Full Name | Dr Michael R Caudle |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Gynecology |
| Location | 2018 Western Ave, Knoxville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114984010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 14502 (Tennessee) | Secondary |
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 14502 (Tennessee) | Primary |
| Entity Name | Cherokee Health Systems |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134128820 PECOS PAC ID: 3577474295 Enrollment ID: O20031119000769 |
News Archive
A new diagnostic tool that shortens the diagnosis of multidrug-resistant tuberculosis (MDR-TB) from eight weeks to two hours should be made available to vulnerable populations according to a WHO expert, Reuters reports.
Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
Kaduna State Nigeria, an established service provider of hitch-free Hajj operations, will be using the M2SYS Bio-Plugin solution, a seamless and easy-to-use fingerprint biometrics system. The software will enable Kaduna to keep a database of records that include every detail related to Hajj, including how many times a pilgrim performed.
Women are substantially underrepresented in clinical trials used to formulate women's guidelines and are affected more than men by low social support after a heart attack, according to two studies in the women-themed issue of Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.
According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael R Caudle, MD 6350 W A J Hwy, Department 100, Talbott, TN 37877-8605 Ph: (800) 355-3565 | Dr Michael R Caudle, MD 2018 Western Ave, Knoxville, TN 37921-5718 Ph: (865) 544-0406 |
News Archive
A new diagnostic tool that shortens the diagnosis of multidrug-resistant tuberculosis (MDR-TB) from eight weeks to two hours should be made available to vulnerable populations according to a WHO expert, Reuters reports.
Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
Kaduna State Nigeria, an established service provider of hitch-free Hajj operations, will be using the M2SYS Bio-Plugin solution, a seamless and easy-to-use fingerprint biometrics system. The software will enable Kaduna to keep a database of records that include every detail related to Hajj, including how many times a pilgrim performed.
Women are substantially underrepresented in clinical trials used to formulate women's guidelines and are affected more than men by low social support after a heart attack, according to two studies in the women-themed issue of Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.
According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.
› Verified 6 days ago
Dr. Periclis Roussis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-331-2020 Fax: 865-331-2019 | |
Dr. George Walton Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-541-1975 Fax: 865-541-1976 | |
Dr. Roy Cox Broady, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th Street, Suite 509, Knoxville, TN 37916 Phone: 865-524-3208 Fax: 865-522-4322 | |
Courtney Roth, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1926 Alcoa Hwy Ste 370, Knoxville, TN 37920 Phone: 865-305-5622 | |
Dr. Lynlee Marie Wolfe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1925 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920 Phone: 865-305-8888 | |
Jeffrey A Keenan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11126 Kingston Pike, Knoxville, TN 37934 Phone: 865-777-0088 Fax: 865-777-2015 | |
Kristopher J. Kimball, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1934 Alcoa Hwy, Ste 478, Knoxville, TN 37920 Phone: 865-305-5622 Fax: 865-305-4580 |